Shares of vaccine makers drop after FDA memo flags reports of child deaths

Shares in major COVID-19 vaccine makers fell on Monday after an internal U.S. Food and Drug Administration (FDA) memo reportedly suggested that vaccinations may have contributed to several child ...

FDA Vaccine Chief Claims COVID Shots Linked to 'At Least 10' Child Deaths but Offers No Data

US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to ...

Milestones Over Sales: The Sanofi Partnership Now Drives Novavax's Outlook

Novavax, Inc. reported 3Q25 EPS loss & declining revenue, but beat revenue expectations & reaffirmed its FY25 guidance. Read ...

Novavax’s R&D Shift and Sanofi Partnership Could Be a Game Changer for NVAX

Novavax, Inc. recently announced at the Jefferies London Healthcare Conference 2025 that it is shifting its focus from direct COVID-19 commercial operations to an expanded research and development ...
WTKR

Biden administration orders millions of Novavax COVID-19 vaccine doses

The Biden administration announced Monday that it would purchase 3.2 million doses of the Novavax COVID-19 vaccine. It will be offered at no cost to states and federal partners. “We remain ...

Study compares immune responses from three major COVID-19 vaccine types

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Seeking Alpha

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season "With today's approval, we will work with our partner Sanofi to provide ...
ABC15 Arizona

FDA authorizes Novavax's protein-based COVID-19 vaccine

The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine is ...